UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase II Conjugates of Urolithins Isolated from Human Urine and Potential Role of β -Glucuronidases in Their Disposition

Drug metabolism and disposition, 2017-06, Vol.45 (6), p.657-665

2017

Volltextzugriff (PDF)

Disposition and metabolic profiling of [(14)C]cerlapirdine using accelerator mass spectrometry

Drug metabolism and disposition, 2014-12, Vol.42 (12), p.2023-2032

2014

Volltextzugriff (PDF)

Pharmacokinetics, Disposition, and Biotransformation of [ 14 C]Omecamtiv Mecarbil in Healthy Male Subjects after a Single Intravenous or Oral Dose

Drug metabolism and disposition, 2021-08, Vol.49 (8), p.619-628

2021

Volltextzugriff (PDF)

Pharmacokinetics, Disposition, and Biotransformation of [14C]Lenacapavir, a Novel, First-in-Class, Selective Inhibitor of HIV-1 Capsid Function, in Healthy Participants Following a Single Intravenous Infusion

Clinical pharmacokinetics, 2024-02, Vol.63 (2), p.241-253

2024

Volltextzugriff (PDF)

Disposition and metabolism of [14C] Sacubitril/Valsartan (formerly LCZ696) an angiotensin receptor neprilysin inhibitor, in healthy subjects

Xenobiotica, 2016-11, Vol.46 (11), p.986-1000

2016

Volltextzugriff (PDF)

Pharmacokinetics and pharmacodynamics of nab-paclitaxel in patients with solid tumors: Disposition kinetics and pharmacology distinct from solvent-based paclitaxel

Journal of clinical pharmacology, 2014-10, Vol.54 (10), p.1097-1107

2014

Volltextzugriff (PDF)

Treatment With Antipsychotics in Pregnancy: Changes in Drug Disposition

Clinical pharmacology and therapeutics, 2018-03, Vol.103 (3), p.477-484

2018

Volltextzugriff (PDF)

Brivaracetam Disposition in Renal Impairment

Journal of clinical pharmacology, 2012-12, Vol.52 (12), p.1927-1933

2012

Volltextzugriff (PDF)

A pregnancy physiologically based pharmacokinetic (p‐PBPK) model for disposition of drugs metabolized by CYP1A2, CYP2D6 and CYP3A4

British journal of clinical pharmacology, 2012-11, Vol.74 (5), p.873-885

2012

Volltextzugriff (PDF)

Disposition, metabolism and mass balance of [14C]apremilast following oral administration

Xenobiotica, 2011-12, Vol.41 (12), p.1063-1075

2011

Volltextzugriff (PDF)

Physiologically Based Modeling of Pravastatin Transporter-Mediated Hepatobiliary Disposition and Drug-Drug Interactions

Pharmaceutical research, 2012-10, Vol.29 (10), p.2860-2873

2012

Volltextzugriff (PDF)

Complex disposition of methylthioninium redox forms determines efficacy in tau aggregation inhibitor therapy for Alzheimer's disease

The Journal of pharmacology and experimental therapeutics, 2015-01, Vol.352 (1), p.110-118

2015

Volltextzugriff (PDF)

Sorafenib hepatobiliary disposition: mechanisms of hepatic uptake and disposition of generated metabolites

Drug metabolism and disposition, 2013-06, Vol.41 (6), p.1179-1186

2013

Volltextzugriff (PDF)

Effects of Pregnancy on CYP3A and P-glycoprotein Activities as Measured by Disposition of Midazolam and Digoxin: A University of Washington Specialized Center of Research Study

Clinical pharmacology and therapeutics, 2008-08, Vol.84 (2), p.248-253

2008

Volltextzugriff (PDF)

Use of Real‐World Data and Physiologically‐Based Pharmacokinetic Modeling to Characterize Enoxaparin Disposition in Children With Obesity

Clinical pharmacology and therapeutics, 2022-08, Vol.112 (2), p.391-403

2022

Volltextzugriff (PDF)

Absorption, Metabolism, Excretion, and the Contribution of Intestinal Metabolism to the Oral Disposition of [14C]Cobimetinib, a MEK Inhibitor, in Humans

Drug metabolism and disposition, 2016-01, Vol.44 (1), p.28-39

2016

Volltextzugriff (PDF)

Bronchopulmonary disposition of IV cefepime/taniborbactam (2–0.5 g) administered over 2 h in healthy adult subjects

Journal of antimicrobial chemotherapy, 2023-03, Vol.78 (3), p.703-709

2023

Volltextzugriff (PDF)

Pharmacogenetics of artemether‐lumefantrine influence on nevirapine disposition: Clinically significant drug–drug interaction?

British journal of clinical pharmacology, 2019-03, Vol.85 (3), p.540-550

2019

Volltextzugriff (PDF)

Food Effect on Rosuvastatin Disposition and Low‐Density Lipoprotein Cholesterol

Clinical pharmacology and therapeutics, 2018-09, Vol.104 (3), p.525-533

2018

Volltextzugriff (PDF)

Imatinib Disposition and ABCB1 (MDR1, P‐Glycoprotein) Genotype

Clinical pharmacology and therapeutics, 2007-07, Vol.82 (1), p.33-40

2007

Volltextzugriff (PDF)

The metabolism and disposition of the oral direct thrombin inhibitor, dabigatran, in humans

Drug metabolism and disposition, 2008-02, Vol.36 (2), p.386-399

2008

Volltextzugriff (PDF)

Common Polymorphisms of CYP2B6 Influence Stereoselective Bupropion Disposition

Clinical pharmacology and therapeutics, 2019-01, Vol.105 (1), p.142-152

2019

Volltextzugriff (PDF)

Metabolism and disposition of [14C]tivantinib after oral administration to humans, dogs and rats

Xenobiotica, 2014-11, Vol.44 (11), p.996-1008

2014

Volltextzugriff (PDF)

Metabolic disposition of the EGFR covalent inhibitor furmonertinib in humans

Acta pharmacologica Sinica, 2022-02, Vol.43 (2), p.494-503

2022

Volltextzugriff (PDF)

Clinical disposition, metabolism and in vitro drug-drug interaction properties of omadacycline

Xenobiotica, 2017-08, Vol.47 (8), p.682-696

2017

Volltextzugriff (PDF)

1 – 25 von 11.403

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieBiopharmaceutics & Drug Disposition

ThemaAdult

ThemaPharmacology & Pharmacy

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(11.181)
Mit Volltextzugriff
(7.603)

Publikationsform

Artikel
(11.403)

Sprache

Englisch
(11.399)
Japanisch
(2.058)
Russisch
(9)
Französisch
(5)
Deutsch
(5)
Norwegisch
(4)
Chinesisch
(2)

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

13 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(11.396)
Journals@Ovid Complete
(7.337)
Wiley Online Library Journals Frontfile Complete
(5.961)
Wiley Online Library Full Collection 2018
(4.149)
Ingenta
(3.903)
Free E-Journal (出版社公開部分のみ）
(3.606)
Publisher or Other Site
(2.960)
IngentaConnect Journals
(2.581)
Springer Nature - Complete Springer Journals
(2.245)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(1.456)
Nexis Uni
(737)
Elsevier ScienceDirect Journals Complete
(504)
Taylor & Francis Current Content Access
(329)
Taylor & Francis Journals Auto-Holdings Collection
(311)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(238)
Taylor & Francis:Master (3349 titles)
(211)
Oxford Journals
(180)
SAGE Complete
(176)
Nature
(168)
Oxford Journals 2020 Medicine
(123)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Phase II Conjugates of Urolithins Isolated from Human Urine and Potential Role of β -Glucuronidases in Their Disposition

Disposition and metabolic profiling of [(14)C]cerlapirdine using accelerator mass spectrometry

Pharmacokinetics, Disposition, and Biotransformation of [ 14 C]Omecamtiv Mecarbil in Healthy Male Subjects after a Single Intravenous or Oral Dose

Pharmacokinetics, Disposition, and Biotransformation of [14C]Lenacapavir, a Novel, First-in-Class, Selective Inhibitor of HIV-1 Capsid Function, in Healthy Participants Following a Single Intravenous Infusion

Disposition and metabolism of [14C] Sacubitril/Valsartan (formerly LCZ696) an angiotensin receptor neprilysin inhibitor, in healthy subjects

Pharmacokinetics and pharmacodynamics of nab-paclitaxel in patients with solid tumors: Disposition kinetics and pharmacology distinct from solvent-based paclitaxel

Treatment With Antipsychotics in Pregnancy: Changes in Drug Disposition

Brivaracetam Disposition in Renal Impairment

A pregnancy physiologically based pharmacokinetic (p‐PBPK) model for disposition of drugs metabolized by CYP1A2, CYP2D6 and CYP3A4

Disposition, metabolism and mass balance of [14C]apremilast following oral administration

Physiologically Based Modeling of Pravastatin Transporter-Mediated Hepatobiliary Disposition and Drug-Drug Interactions

Complex disposition of methylthioninium redox forms determines efficacy in tau aggregation inhibitor therapy for Alzheimer's disease

Sorafenib hepatobiliary disposition: mechanisms of hepatic uptake and disposition of generated metabolites

Effects of Pregnancy on CYP3A and P-glycoprotein Activities as Measured by Disposition of Midazolam and Digoxin: A University of Washington Specialized Center of Research Study

Use of Real‐World Data and Physiologically‐Based Pharmacokinetic Modeling to Characterize Enoxaparin Disposition in Children With Obesity

Absorption, Metabolism, Excretion, and the Contribution of Intestinal Metabolism to the Oral Disposition of [14C]Cobimetinib, a MEK Inhibitor, in Humans

Bronchopulmonary disposition of IV cefepime/taniborbactam (2–0.5 g) administered over 2 h in healthy adult subjects

Pharmacogenetics of artemether‐lumefantrine influence on nevirapine disposition: Clinically significant drug–drug interaction?

Food Effect on Rosuvastatin Disposition and Low‐Density Lipoprotein Cholesterol

Imatinib Disposition and ABCB1 (MDR1, P‐Glycoprotein) Genotype

The metabolism and disposition of the oral direct thrombin inhibitor, dabigatran, in humans

Common Polymorphisms of CYP2B6 Influence Stereoselective Bupropion Disposition

Metabolism and disposition of [14C]tivantinib after oral administration to humans, dogs and rats

Metabolic disposition of the EGFR covalent inhibitor furmonertinib in humans

Clinical disposition, metabolism and in vitro drug-drug interaction properties of omadacycline

Aktive Filter

Suchergebnisse filtern